TNFalpha up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling

Cell Tissue Res. 2009 Apr;336(1):67-77. doi: 10.1007/s00441-009-0751-8. Epub 2009 Feb 13.

Abstract

Our aim has been to characterize the molecular mechanisms regulating the expression of the channel-forming tight-junctional protein claudin-2 in response to the pro-inflammatory cytokine tumor necrosis factor-alpha (TNFalpha), which is elevated, for example, in active Crohn's disease. TNFalpha caused an 89% decrease of the paracellular resistance in colonic HT-29/B6 cells, whereas transcellular resistance was unaltered. The claudin-2 protein level was increased by TNFalpha without changes in subcellular tight-junctional protein localization as revealed by confocal laser scanning microscopy. Enhanced gene expression was identified as the source of this increase, since claudin-2-specific mRNA and promoter activity was elevated, whereas mRNA stability remained unaltered. Specific inhibitors and phospho-specific antibodies revealed that the increased gene expression of claudin-2 after TNFalpha treatment was mediated by the phosphatidylinositol-3-kinase pathway. Thus, the up-regulation of claudin-2 by TNFalpha is attributable to the regulation of the expression of the gene, as a result of which epithelial barrier function is disturbed, for example, during chronic intestinal inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromones / pharmacology
  • Claudins
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • HT29 Cells
  • Humans
  • Intestinal Mucosa / metabolism
  • Membrane Proteins / genetics*
  • Membrane Proteins / metabolism
  • Morpholines / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphatidylinositol 3-Kinases / physiology*
  • Phosphoinositide-3 Kinase Inhibitors
  • Signal Transduction / drug effects
  • Tight Junctions / genetics
  • Tight Junctions / metabolism
  • Tissue Distribution
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Up-Regulation / drug effects

Substances

  • CLDN2 protein, human
  • Chromones
  • Claudins
  • Enzyme Inhibitors
  • Membrane Proteins
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Tumor Necrosis Factor-alpha
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one